Ingevity Corporation (NGVT) — Fair Value Analysis

Base-case fair value (P50): $55.00 · Current price: $76.77 · Verdict: Overvalued

The Verdict on NGVT

Monte Carlo simulations suggest INGEVITY CORP (NGVT) is currently Fairly Valued. Our analysis indicates a median fair value (P50) of $55.00, compared to the current market price of $76.77. This implies a -28.4% difference, positioning NGVT closely around its intrinsic value based on our probabilistic models. While some downside scenarios exist from the current price, the overall distribution points to a balanced risk/reward profile at this valuation.

How NGVT stacks up against peers

NGVT's operational and financial health is categorized as average when compared to its sector peers. This average quality tier suggests that NGVT performs in line with industry standards across key metrics, neither presenting significant competitive advantages nor glaring weaknesses. This standing helps contextualize why the stock trades near its $76.77 relative to the median fair value of $55.00, as its fundamental quality doesn't warrant a substantial premium or discount based on its peer group. The -28.4% figure reflects this equilibrium.

What this means for investors

For investors considering INGEVITY CORP (NGVT), the Fairly Valued verdict, derived from thousands of Monte Carlo simulations, suggests the stock is currently trading close to its intrinsic worth. With a median fair value of $55.00 against the current price of $76.77, the -28.4% implies limited immediate alpha potential based on our P50 estimate. Given NGVT's average quality tier, any significant outperformance would likely require operational improvements or a shift in market sentiment beyond current projections. For a deeper understanding, including bear-case (P10) and bull-case (P90) scenarios and their associated probabilities, sign up for FairCurve to see the full distribution and track NGVT's fair value as new fundamentals are released.